KaloBios pharmaceuticals Inc. KBIO, -5.09% disclosed in a filing Wednesday that it acquired a delisting discover from the Nasdaq stock Market. The Nasdaq’s causes for the delisting integrated the latest criminal indictment and arrest of controlling shareholder Martin Shkreli, the arrest of former outside assistance Evan Greebel, civil complaints filed in opposition to Shkreli and Greebel by way of the U.S. Securities and change fee and the company’s failure to file a quarterly document in time. separately, KaloBios said its independent accountant, Marcum LLP, resigned on Dec. 21, after being the corporate’s accountant for simply thirteen days. KaloBios mentioned in an SEC filing that it has no longer yet decided if it’s going to appeal the Nasdaq’s resolution. If it would not file an appeal by means of Dec. 28, the inventory shall be suspended at the opening of business on Dec. 30. The stock has been halted on the grounds that Dec. 17, when Shkreli was once arrested, while the Nasdaq awaited more knowledge.
This entry passed throughout the Full-textual content RSS service – if that is your content material and you might be reading it on someone else’s site, please learn the FAQ at fivefilters.org/content material-only/faq.php#publishers.